|
Thymus Therapy - the basis of the non-specified cancer-immune-therapy
The expression thymus therapy stands for standard injection of specific thymus hormones, the so-called thymus peptides. Thymus therapy is an important, if not the most important non-specific base immunotherapy. This therapy causes activation and balancing of cell defense. Thymus therapy goes back to Dr. Elis Sandberg, Sweden, who already achieved notable success in the treatment of chronic deseases and cancer with his use of the macromolecular THX (thymus total extract) in 1938. By the 80's, Sandberg had successfully treated over 50,000 patients. In many patients he additionally noticed an euphoric and anti-aging effect.
Dr. Sandberg tried his first therapy on a cow which was to be slaughtered because of a malignant sarcoma. After short treatment with THX, the tumour disappeared. This was the start for his research and therapy with thymus total extract.
Only in 1960, the Australian Immunologist J. Miller, Melbourne, discovered the functions of the thymus organ and its trained thymus lymphocytes and their true significance for the immune system. That time marked the onset of thymus research worldwide. We know today, that the thymus gland or Bries gland, is the central organ of the body's immune system. White blood cells built in the bone marrow reach the thymus gland as immature lymphoma (progenitor cells). Only 10% of those progenitor cells are marked as suitable for the body's immune system and get trained in the thymus gland.
They are trained as "special police and cleansing commandos" of the body, monitored, kept on alert and brought into use when needed. The purpose of this system is to recognize the body's own cells, to detect foreign ones such as bacteria, viruses or cancer cells, to attack and destroy them. A helathy immune system is capable of destroying about one million cancer cells on its own. If the defense system is weakened, an even smaller number of cancer cells is sufficient enough to grow into a tumor, especially if the appropriate breeding ground is found within the body.
The most important cells in the fight against the intruders can be classified (in short) as:
1. Helper cells that are involved in the growth of antibodies and activate natural killer and cytotoxic cells.
2. Suppressor cells (suppressors), responsible for preventing the formation of excessive antibodies and excessive immune reactions.
3. Killer cells, which recognize, attack and destroy foreign cells together with the so-called cytotoxic cells.
4. Long-lived Memory cells (Memory cells), which are responsible for storing information and identifying "foreign" or "own".
In humans, the thymus gland is located behind the sternum and consists of 2 lobes.
It is still non-existent in embryos and non functional. Newborn mammals, also the human, are nonviable without the thymus gland. Only when in contact with the environment, which means after birth, humans and animals start to develop their own body's immune system. The more a growing child is confronted with factors from the outside world (e.g. dirt), the better the thymus gland and thus the defense system will operate. The maximum function of the thymus gland will be reached around the time of puberty. The thymus gland shrinks with increasing age and thus the defense, resulting out of the thymus hormones, decreases continuously. At 50 years of age, only 15% of the former functional thymus gland tissue is still available. That has serious consequences:
The thymus-related immune deficiency increases with age; removing the major thymus peptides leads to increased infections, chronic diseases and cancer.
It is worsened by continuous stress, excess weight and bad nutrition as well as lack of exercise. Tumor patients usually show a disturbed, suppressed immune system. Intrusive surgeries, chemotherapy, radiation, cortison treatment and immunosuppressive drugs (drugs that suppress the immune system) lead additionally to temporary or longterm, oftentimes massive immunity deficiency. The number of defense cells in the blood can be increased and their functionality improved or restored through appropriate compounds of veal glands (thymus injections). Thymus preparations with lower or higher molecular amounts of thymus peptides (fresh, dried, frozen) as well as thymus fractions are used.
In cancer treatment, it is important that specific thymic hormones (Thymosin alfa 1, Thymosin Beta 4 and Thymulin) are adequately available.
These are crucial for the upkeep and the restoration of a functional defense system. Both the thymus hormones of the different thymus compounds and the anticipated activation of the body's defense function are measurable in the labratory. (Ask your therapist about the thymus hormone composition of the administered drugs). With over 40 different therapeutically effective factors within the thymus gland, but not all of them sufficiently researched, it is not advisable to use single hormones, but the entire thymus. The thymus total extract THX has the highest proportion of the most important immune regulating thymus hormones and entails a very measurable T-lymphocytes activation. The indication for the thymus extract therapy results from the above:
1. as anti-aging therapy
2. as treatment of chronic diseases, especially those associated with immune deficiency.
3. as supplemental cancer therapy
a) as cancer prevention (cancer prophylaxis)
b) as supplemental therapy before and after surgery
before and after chemotherapy
before, during and after radiation
c) to reduce recidivism (relapse prevention)
(to prevent recidivism a treatment with 15 injections per year for life is recommended)
d) for patients, for which no conventional therapy is possible anymore.
Hereby, the general conditions can be improved and the infection rate can
be reduced.
Prior to every thymus therapy an extensive immune diagnostics check should be conducted.
Scientists of the Monash University describe the restoration of the thymus functions (the thymus therapy) for cancer disease treatments, auto immune suffering and HIV, as the biggest breakthrough in 20 years. (BOYD, R. Thymustherapy breakthrough in treating cancer and HIV/AIDS Source: unweb@adm.monash.edu.au 05. 06. 2007) Prof. Dr. med. unweb@adm.monash.edu.au 06.05.2007) Prof. Dr. med. Richard Schilsky (Chicago), President of ASCO 2009, is of the opinion that in the future, the therapy of cancer diseases will be most influenced by immunotherapy. (Immunotherapy against cancer, "Deutsches Ärzteblatt" vol. 106, edition 48; 2009). The context shows, that the thymus therapy for most cancer types- no matter in what stage- shown (exeptions are haematological diseases, for which- depending on the course of the disease- an individual decision has to be made whether or not a thymus therapy is suitable).
click to enlarge
| |
